Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing tumors
- Gilles Bioley
- , Philippe Guillaume
- , Immanuel Luescher
- , Nina Bhardwaj
- , Gregory Mears
- , Lloyd Old
- , Danila Valmori
- , Maha Ayyoub
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations